• Entertainment
  • Finance
  • Marketing
  • Real Estate
  • Technology
  • Social
National Journal Community Of e-Experts
Finance 0

Alexion To Acquire Sweden’s Wilson Therapeutics For $855M In Cash

By Kurt Osterberg · On April 11, 2018

Alexion Pharmaceuticals (ALXN) and Wilson Therapeutics AB announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer, through a wholly-owned subsidiary.

Wilson Therapeutics, based in Stockholm, Sweden, develops therapies for patients with rare copper-mediated disorders. The company’s WTX101 is in Phase 3 development as a treatment for Wilson disease. Alexion will acquire Wilson Therapeutics through a tender offer that was launched this morning whereby Alexion, through a wholly owned subsidiary, has offered SEK 232 in cash for each outstanding share of Wilson Therapeutics. The total equity value of the transaction amounts to approximately $855M. The Independent Committee of Wilson’s board has unanimously recommended Wilson Therapeutics shareholders accept the offer and Alexion’s board also unanimously approved the offer. Alexion has obtained shareholder support agreements from the four largest shareholders accounting for 57.4% of Wilson Therapeutics’ outstanding shares and two additional shareholders accounting for 8.7% for a total of 66.1% of Wilson Therapeutics’ outstanding shares, to the effect that these shareholders have undertaken to accept the offer on certain terms. In addition, Polar Capital, holding 7.3% of Wilson Therapeutics’ outstanding shares, has expressed its support for, and intends to accept, the offer, for a total support of 73.4%. The acquisition of Wilson Therapeutics requires approval of relevant regulatory authorities, and Alexion expects to obtain such approvals prior to the end of the acceptance period. The tender offer is expected to complete and the transaction is expected to close in Q2 of 2018. Alexion intends to finance the acquisition through cash on hand.

BofA Merrill Lynch is acting as Alexion’s lead financial advisor.
 

Print Friendly, PDF & Email

Share Tweet

Kurt Osterberg

You Might Also Like

  • Finance

    Bored Ape Metaverse Launch Date set for April 30

  • Finance

    Celebrity Backed NFT Collections to Invest in 2022

  • Finance

    Bored Ape Metaverse Launch Date set for April 30

No Comments

Leave a reply Cancel reply

Top Finance

  • 3 Best Large-Cap Blend Mutual Funds For Enticing Returns 3 Best Large-Cap Blend Mutual Funds For Enticing Returns
  • Hedge Funds In The US Hedge Funds In The US
  • What is Value Chain Analysis? How to Deliver Value & Gain a Competitive Advantage What is Value Chain Analysis? How to Deliver Value & Gain a Competitive Advantage
  • 5 Ridiculously Useful Non-Monetary Reward Examples that Improve Employee Engagement 5 Ridiculously Useful Non-Monetary Reward Examples that Improve Employee Engagement
  • Chart: Amazon’s Dominance In Ecommerce Chart: Amazon’s Dominance In Ecommerce

New Posts

  • Bored Ape Metaverse Launch Date set for April 30

    Bored Ape Metaverse Launch Date set for April 30

    April 24, 2022
  • Celebrity Backed NFT Collections to Invest in 2022

    Celebrity Backed NFT Collections to Invest in 2022

    April 24, 2022
  • Bored Ape Metaverse Launch Date set for April 30

    Bored Ape Metaverse Launch Date set for April 30

    April 24, 2022
  • Mutant Ape Yacht Club Hits 32 ETH All Time High Price Floor

    Mutant Ape Yacht Club Hits 32 ETH All Time High Price Floor

    April 22, 2022
  • Rare CryptoPunk #7756 sells for $3.2 million (1050 ETH)

    Rare CryptoPunk #7756 sells for $3.2 million (1050 ETH)

    April 22, 2022
  • About
  • Contact Us
  • Privacy & Policy
  • Sitemap
  • Terms of use

Copyright © 2018-2021 NJCEE. All Rights Reserved.